Faculty profile

Andrew Loblaw

Back to faculty

ProfessorDepartment of Radiation OncologyUniversity of Toronto

Andrew Loblaw

Professor

Department of Radiation Oncology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
72 publications in the last five years, latest in 2027.
Senior (last) author on 24 recent papers, a sign of leading a research group.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

193

Publications

2,150

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial.
Clinical and translational radiation oncology · 2027 · senior author
Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial
European Urology · 2026
The Benefits and Harms of Screening for Prostate Cancer in Adults Aged 18 Years and Older: A Systematic Review
Current Oncology · 2026

All 193 publications

From the 150 most recent of 193 publications.

Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial.

Alayed Y, Gopaul D, Mendez LC, Kwan W, Liu SK, Chu W, Tseng CL, Cheung P, Vesprini D, Chung H, Morton G, Correa R, Musunuru B, Davidson M, Ravi A, Deabreu A, Mamedov A, Poon E, Zhang L, Loblaw A

Clinical and translational radiation oncology2027Senior author

DOI: 10.1016/j.ctro.2026.101256 PMID: 42750816

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial

Cooper S, Patel J, Moore C, Ostler P, van der Voet H, Loblaw A, Chu W, Ford D, Tolan S, Jain S

European Urology20262 citations

DOI: 10.1016/j.eururo.2026.05.034

The Benefits and Harms of Screening for Prostate Cancer in Adults Aged 18 Years and Older: A Systematic Review

Bennett A, Vyas N, Shaver N, Almoli F, Kibret T, Loblaw A, Del Giudice L, Yao X, Skidmore B, Brouwers M

Current Oncology20261 citations

DOI: 10.3390/curroncol33040199

Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.

Alayed Y, Loblaw A, Mendez LC, Correa RJM, Dhar A, Laidley D, Warner A, Fakir H, Wronski M, Conyngham J, Kassam Z, Helou J, D'Souza DP, Velker V, Lock M, Ahmad B, Bauman GS

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111786 PMID: 42744076

Development and pilot evaluation of a virtual reality simulator for HDR prostate brachytherapy.

Varlukhin A, Smith M, Alam F, Tagger A, Morton G, Paudel M, Loblaw A, Mendez LC, Hoover D, Karshafian R, Nusrat H

Brachytherapy2026

DOI: 10.1016/j.brachy.2026.05.006 PMID: 42498540

Case - A rare ocular recurrence of prostate cancer Adenocarcinoma metastasis to the vitreous.

Birchenough J, Waldron J, Del Castillo R, Krcek R, Krema H, Loblaw A

Canadian Urological Association journal = Journal de l'Association des urologues du Canada2026Senior author

DOI: 10.5489/cuaj.9388 PMID: 41848540

Androgen Deprivation Therapy and Cardiovascular Health: Challenges and Opportunities in Prostate Cancer Care.

Fernández Alonso S, López Campos F, Büchser D, Guardado S, Andreescu J, Vásquez W, Castaño A, Gil Moradillo J, García González L, Loblaw A, Couñago F

Archivos espanoles de urologia2026

DOI: 10.56434/j.arch.esp.urol.20267905.87 PMID: 42438869

From Clinical Trials to Clinical Practice-Patterns of Practice Survey on Prostate SABR in Australia and New Zealand.

Kang T, Armstrong S, Chander S, de Leon J, Finnigan R, Gill S, Guerrieri M, Hayden A, Higgs B, Holt T, Jones M, Lin YH, Sasso G, Tejani N, Murthy V, Loblaw A, Ong WL

Advances in radiation oncology2026

DOI: 10.1016/j.adro.2026.102144 PMID: 42656846

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.

Seung SJ, Bayani J, Nguyen L, Liu N, Gatley J, Wong A, Richard E, Barker SL, Lee AY, Bartlett JMS, Berman D, Loblaw A, Earle CC, Mittmann N

Cancers2026

DOI: 10.3390/cancers18101580 PMID: 42192940

Bowel Bag Dosimetric Parameters for Ultrahypofractionated Pelvic Elective Nodal Irradiation in Prostate Cancer.

Ong WL, Davidson M, Wronski M, Kang T, Cheung P, Chu W, Chung H, Liu S, Morton G, Tseng CL, Vesprini D, Zhang L, Poon C, Loblaw A

International journal of radiation oncology, biology, physics2026Senior author

DOI: 10.1016/j.ijrobp.2025.08.014 PMID: 40819809

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Andrew Loblaw

Research

Latest papers

Prostate and pelvic SABR with or without a focal boost: results from a multicenter phase II prospective clinical trial.

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial

The Benefits and Harms of Screening for Prostate Cancer in Adults Aged 18 Years and Older: A Systematic Review

Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial.

Development and pilot evaluation of a virtual reality simulator for HDR prostate brachytherapy.

Case - A rare ocular recurrence of prostate cancer Adenocarcinoma metastasis to the vitreous.

Androgen Deprivation Therapy and Cardiovascular Health: Challenges and Opportunities in Prostate Cancer Care.

From Clinical Trials to Clinical Practice-Patterns of Practice Survey on Prostate SABR in Australia and New Zealand.

Population-Level Resources and Costs Associated with Low-Risk Prostate Cancer Patients on Active Surveillance.

Bowel Bag Dosimetric Parameters for Ultrahypofractionated Pelvic Elective Nodal Irradiation in Prostate Cancer.

Frequent collaborators

Gerard Morton

Stanley Liu

Ewa Szumacher

Antonio Finelli

Gregory Pond

Glenn Bauman

Alejandro Berlin

Lee Chin

Sebastien Hotte

George Rodrigues

Ian Stuart Dayes

Bharati Bapat

Jeff Chen

Xiaomei Yao

Katherine Zukotynski

Arjun Sahgal

Nicole Mittmann

Jonathan Thiessen

Tony Panzarella

Theos Tsakiridis

Julian Little

Ting-Yim Lee

Vasundara Venkateswaran

Aaron Ward

Jenna Sykes

Olli Saarela

Katherine Zukotynski